We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Suggests Alternatives for Demonstrating CGMP Compliance for Combination Products
The item has been added to your shopping cart.
FDA Suggests Alternatives for Demonstrating CGMP Compliance for Combination Products
The FDA released a list of alternative suggestions for complying with CGMP requirements for drug combination products that covers stability testing, release for distribution, reserve samples and special testing requirements.